Status:
COMPLETED
Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Detailed Description
Clinical data (prostate-specific antigen \[PSA\] response after radiotherapy) are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Eligibility Criteria
Inclusion
- Prostate cancer treated with radiotherapy +/- hormones
Exclusion
- Prostatectomy
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00126815
Start Date
February 1 2004
End Date
April 1 2008
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2